Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
Article in Nature Communications (April 2024)
The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.
Article in Nature Communications (April 2024)
Article in Journal of Immunological Methods (March 2024)
Article in Cells (February 2024)